Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)Business Wire • 08/08/23
These stocks could be the next Magnificent Seven market leaders, says Goldman SachsMarket Watch • 07/04/23
Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific SessionsBusiness Wire • 06/22/23
Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United KingdomBusiness Wire • 06/20/23
New Highs: Diabetes Stock Breaks Out. Cement Maker Surges Past Buy Point.Investors Business Daily • 05/05/23
4 Medical Products Stocks to Capitalize on the Industry's RecoveryZacks Investment Research • 05/05/23
Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)Business Wire • 05/04/23